Advertisement
New Zealand markets close in 1 hour 3 minutes
  • NZX 50

    12,366.53
    +40.93 (+0.33%)
     
  • NZD/USD

    0.6001
    -0.0011 (-0.18%)
     
  • NZD/EUR

    0.5507
    -0.0012 (-0.22%)
     
  • ALL ORDS

    8,157.70
    -51.50 (-0.63%)
     
  • ASX 200

    7,921.00
    -50.60 (-0.63%)
     
  • OIL

    80.61
    +0.48 (+0.60%)
     
  • GOLD

    2,408.10
    +9.00 (+0.38%)
     
  • NASDAQ

    19,522.62
    -182.48 (-0.93%)
     
  • FTSE

    8,155.72
    -49.17 (-0.60%)
     
  • Dow Jones

    40,287.53
    -377.47 (-0.93%)
     
  • DAX

    18,171.93
    -182.87 (-1.00%)
     
  • Hang Seng

    17,568.80
    +151.12 (+0.87%)
     
  • NIKKEI 225

    39,648.95
    -414.84 (-1.04%)
     
  • NZD/JPY

    94.4510
    -0.1820 (-0.19%)
     

AbbVie Declares Quarterly Dividend

NORTH CHICAGO, Ill., June 21, 2024 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share.

The cash dividend is payable August 15, 2024, to stockholders of record at the close of business on July 15, 2024.

Since the company's inception in 2013, AbbVie has increased its dividend by more than 285 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

AbbVie logo
AbbVie logo

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302179018.html

SOURCE AbbVie